Wire Stories

Global Compound Feed Market (2022 to 2027) – Growth, Trends, COVID-19 Impact and Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Compound Feed Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to…

4 years ago

Global Screenwriter Creation Forum was Held in Changzhi, where Screenwriters Unlocked the Success Mystery of Main Melody Teleplays

MACAU, China--(BUSINESS WIRE)--Recently, as one of the series of events of the World Film Industry Conference and sponsored by Aollywood…

4 years ago

Pakistan Construction Industry Report 2022: Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Market Size, Trends and Forecasts, 2017-2021 & 2022-2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pakistan Construction Market Size, Trends and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and…

4 years ago

Australia Construction Industry Report 2022: Analysis, Trends and Forecasts, 2017-2021 & 2022-2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trends and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and…

4 years ago

PPG provides third quarter financial results update; reports soft demand conditions in Europe and China expected to continue into fourth quarter

PITTSBURGH--(BUSINESS WIRE)--PPG (NYSE:PPG) today announced that it expects third quarter 2022 adjusted earnings per diluted share to be between 5%…

4 years ago

Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGene in China

– Collaboration with BeiGene is part of Immune-Onc’s global clinical development strategy targeting the LILRB family of myeloid checkpoints –…

4 years ago

PPG provides third quarter financial results update; reports soft demand conditions in Europe and China expected to continue into fourth quarter

PITTSBURGH--(BUSINESS WIRE)--PPG (NYSE:PPG) today announced that it expects third quarter 2022 adjusted earnings per diluted share to be between 5%…

4 years ago

Phoenix Motorcars Engages IAT Automobile Technology to Advance Gen 4 Development

Accelerates development time, increases quality and reduces costs of Phoenix’s Gen 4 vehicles ANAHEIM, Calif.--(BUSINESS WIRE)--Phoenix Motor Inc. (Nasdaq: PEV)…

4 years ago

Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGene in China

– Collaboration with BeiGene is part of Immune-Onc’s global clinical development strategy targeting the LILRB family of myeloid checkpoints –…

4 years ago